Research & Treatment News articles

asco

Advocate Spotlight: Suzan’s Thoughts On ASCO

Advocate Spotlight: Suzan’s Thoughts On ASCO

by Fight CRC advocate Suzan Mayberry ASCO – WHAT AN EXPERIENCE What a privilege to attend the 2014 ASCO (American Society of Clinical Oncology) conference at McCormick Place in the windy city of Chicago. This conference was every bit of exciting as my first day of university. People from all over the world were there, and McCormick Place was so huge. Some of the sessions held more people than any class at university. The crowd was filled primarily with doctors and oncologists, but some were not, like me. I am an advocate for Fight Colorectal Cancer (Fight CRC). As an advocate, Fight CRC encourages me to continuously expose myself to the

Patient-Resource-Facebook-Group

Fight CRC Patient Resource Group – Launch

FINDING RESOURCES Colorectal cancer resources shouldn’t be hard to find. Fight Colorectal Cancer knows that many patients, caregivers and survivors find themselves asking the same questions:  Where can I find reliable and trusted information about my diagnosis and treatment plan?  How do I stay up-to-date on the latest colorectal cancer news?  Is there one place where I can find colorectal cancer resources? The answer to these frequently asked questions is Fight Colorectal Cancer’s new Patient Resource Facebook group. Fight CRC will guide patients and their families through screening, diagnosis, treatments, side effects and more with reliable and vetted educational information. We will empower you with the latest medical news and the

fightcrc-researchupdate-tas-102

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work with drug companies to stay up-to-date on the latest treatments so that we can let patients and families know what’s happening in the science of colorectal cancer. For the last year, Fight Colorectal Cancer staff have tracked the progress of the drug TAS-102 – an oral chemo drug currently being evaluated in clinical trials for patients with metastatic refractory colorectal cancer. At the ESMO World

fight-crc-asco-team

Cancer Prevention: Skinnier, Wealthier & Healthier

by Andi Dwyer, Director of Health Promotion  A few weeks ago at the American Society of Clinical Oncology meeting, prevention was a hot topic! The news of prevention and exploring opportunities for early detection was extremely interesting. Before the next ASCO meeting, I have high hopes that we all can identify ways to bring early detection and prevention, for not just us, but others as well.  My contribution – I need to lose some weight! Skinnier & Wealthier Speakers and presenters at the ASCO meeting noted that the impact of obesity on cancer is an initiative and priority. It is estimated that one-third of all adults and 17 percent of children are

guidethefight

Fight Colorectal Cancer Releases “Guide in the Fight” Resource Book for Stage III & Stage IV Colorectal Cancer Patients

FOR IMMEDIATE RELEASE ALEXANDRIA, Va., June 17, 2014 – Today Fight Colorectal Cancer released its new patient education resource, Your Guide in the Fight. Your Guide in the Fight answers common questions and provides practical tips for those fighting stage III and stage IV colorectal cancer (advanced stage disease.) The resource walks patients through a cancer diagnosis step-by-step, covering topics ranging from second opinions, clinical trials, financial assistance, intimacy issues, ostomy support, hospice, survivorship and more. The book is written to assist patients and caregivers from the first day of diagnosis to the last day of treatment.   A 10-step, 65 Page workbook, the Guide provides information about medical terms,

First-Line Treatment Approved for Stage IV Colorectal Cancer

There is new first-line treatment (standard of care to start treatment) giving as many as 60% of the stage IV colorectal cancer patients more options for treatment. Previously, most stage IV patients undergoing chemotherapy would be recommended to go on FOLFOX and bevacizumab (Avastin). Patients would receive this first set of drugs (called first-line) and if the cancer continued to grow, then other treatment options would be explored. Recently, the FDA approved an additional drug to be used as a first-line option for some stage IV patients. But this is for a specific set of patients based on their tumor gene type, known as biomarker. The new targeted therapy panitumumab

Webinar Wrap-Up – Family First – Genetic Syndromes by Heather Hampel

Patients, caregivers and family members use our webinars each month to learn more about the battle against colorectal cancer and find the news they need to stay informed. At Fight Colorectal Cancer, we believe that education empowers those affected by colorectal cancer to take control of their lives. Below is Q&A with Heather Hampel, our presenter of the webinar “Family First: What You Need To Know About Genetic Testing, Family History & Colorectal Cancer.“   Q&A with Heather Q: I would like to know when my children need to start getting colonoscopies. (They’re 32 and 25). Also would like to know if there is any connection, at all, between an astrocytoma brain tumor and

ASCO-booths

Andi’s Highlights on ASCO 2014

by Andi Dwyer, Director of Health Promotion, Fight Colorectal Cancer Working in the cancer prevention and survivorship field for nearly ten years, I was elated to attend my first ASCO.  However, nothing prepared me for the 35,000 people from throughout the world, gathered to unveil the latest in ‘all things’ cancer.  I came in with a notion this was a research conference; I discovered, it was so much more. Policy, advocacy, pharmaceutical, basic research and clinical/medical science from the entire planet, collided into a single city for a solid four days.  It was intense and complete with opportunity and challenge but none-the-less, a guide for this year and beyond. ASCO info about Biomarkers

Greys Anatomy Farting Episode – It’s True!

Recently, the colorectal cancer community received a ‘nod’ from the widely popular ABC show Grey’s Anatomy. In the episode a young woman who’d survived cancer struggled to control her flatulence and bowel movements – many recaps over the past few weeks have even referred to her as “The Farter.” It’s raised many questions within the community – namely, is this true? Do you pass gas a lot more once you’ve had colorectal surgery? To firm this up, we asked Dr. James Waller, a colorectal surgeon from Evansville, Indiana to talk to us about farting. Dr. Waller provides young adult survivors at The Colon Club with answers to some of these obscure questions on a

Top